1887

Abstract

The ciprofloxacin-resistance P gene, encoded by the pUM505 plasmid, isolated from a clinical isolate, confers an enzymatic mechanism of antibiotic phosphorylation, which is ATP-dependent, that decreases ciprofloxacin susceptibility. Homologous P genes are distributed across extended spectrum beta-lactamase (ESBL)-producing isolates obtained from Mexican hospitals and which confer decreased susceptibility to CIP. The analysis of sequences of the CrpP of proteins showed that the residues Gly7, Thr8, Asp9, Lys33 and Gly34 (located at the -terminal region) and Cys40 (located at the C-terminal region) are conserved in all proteins, suggesting that these residues could be essential for CrpP function. The aim of this study was to investigate the amino acids essential to ciprofloxacin resistance, which is conferred by the CrpP protein of pUM505 plasmid. Mutations in the codons encoding Gly7, Asp9, Lys33 and Cys40 of CrpP protein from pUM505 were generated by PCR fusion. The results showed that all mutations generated in CrpP proteins increased ciprofloxacin susceptibility in . In addition, the CrpP modified proteins were purified and their enzymatic activity on ciprofloxacin was assayed, showing that these modified proteins do not exert catalytic activity on ciprofloxacin. Moreover, by infrared assays it was determined that the modified proteins were are not able to modify the ciprofloxacin molecule. Our findings are the first report that indicate that the amino acids, namely Gly7, Asp9, Lys33 and Cys40, which are conserved in the CrpP proteins, possess an essential role for the enzymatic mechanism that confers ciprofloxacin resistance.

Funding
This study was supported by the:
  • Coordinación de la Investigación Científica (Award 2.6)
    • Principle Award Recipient: Víctor Meza Carmen
  • Coordinación de la Investigación Científica (Award 2.35)
    • Principle Award Recipient: Martha Isela Ramirez-Diaz
  • Consejo Nacional de Ciencia y Tecnología
    • Principle Award Recipient: Víctor M. Chávez-Jacobo
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000889
2020-01-28
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/166/4/367.html?itemId=/content/journal/micro/10.1099/mic.0.000889&mimeType=html&fmt=ahah

References

  1. Naeem A, Badshah SL, Muska M, Ahmad N, Khan K. The current case of quinolones: synthetic approaches and antibacterial activity. Molecules 2016; 21:268 [View Article][PubMed]
    [Google Scholar]
  2. Redgrave LS, Sutton SB, Webber MA, Piddock LJV. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 2014; 22:438–445 [View Article][PubMed]
    [Google Scholar]
  3. Hooper DC, Jacoby GA. Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci 2015; 1354:12–31 [View Article][PubMed]
    [Google Scholar]
  4. Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Curr Opin Pharmacol 2014; 18:56–60 [View Article][PubMed]
    [Google Scholar]
  5. Ventola CL. The antibiotic resistance crisis: Part 1: causes and threats. P T: a peer-reviewed journal for formulary management 2015; 40:277–283[PubMed]
    [Google Scholar]
  6. Robicsek A, Strahilevitz J, Jacoby GA, MacIelag M, Abbanat D et al. Fluoroquinolone-Modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12:83–88 [View Article][PubMed]
    [Google Scholar]
  7. Aldred KJ, Kerns RJ, Osheroff N. Mechanism of quinolone action and resistance. Biochemistry 2014; 53:1565–1574 [View Article][PubMed]
    [Google Scholar]
  8. Chávez-Jacobo VM, Hernández-Ramírez KC, Romo-Rodríguez P, Pérez-Gallardo RV, Campos-García J et al. CrpP Is a novel ciprofloxacin-modifying enzyme encoded by the Pseudomonas aeruginosa pUM505 plasmid. Antimicrob Agents Chemother 2018; 62:e02629-17 [View Article][PubMed]
    [Google Scholar]
  9. Lee JK, Lee YS, Park YK, Kim BS. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa . Int J Antimicrob Agents 2005; 25:290–295 [View Article][PubMed]
    [Google Scholar]
  10. Chávez-Jacobo VM, Hernández-Ramírez KC, Silva-Sánchez J, Garza-Ramos U, Barrios-Camacho H et al. Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals. J Antimicrob Chemother 2019; 74:1253–1259 [View Article][PubMed]
    [Google Scholar]
  11. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985; 33:103–119 [View Article][PubMed]
    [Google Scholar]
  12. Green MR, Sambrook J. Molecular Cloning: a Laboratory Manual, 4th ed. NY: Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 2012
    [Google Scholar]
  13. Burgess RR. Elution of proteins from gels. Methods in Enzymology Chapter 32 New York: Academic Press; 2009 p 565
    [Google Scholar]
  14. Kramer JR, Matsumura I. Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costs. PLoS One 2013; 8:e76687 [View Article][PubMed]
    [Google Scholar]
  15. McIvor RA, Hubley CE. Infrared spectra of organo-phosphorus compounds: III. phosphoramidates, PHOSPHORAMIDOTHIONATES, and related compounds. Can J Chem 1959; 37:869–876 [View Article]
    [Google Scholar]
  16. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. 95 Hoboken, NJ: John Wiley & Sons; 2005
  17. Egorov AM, Ulyashova MM, Rubtsova MY. Bacterial enzymes and antibiotic resistance. Acta Naturae 2018; 10:33–48 [View Article][PubMed]
    [Google Scholar]
  18. Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr 2016; 4: [View Article][PubMed]
    [Google Scholar]
  19. Smith CA, Baker EN. Aminoglycoside antibiotic resistance by enzymatic deactivation. Curr Drug Targets Infect Disord 2002; 2:143–160 [View Article][PubMed]
    [Google Scholar]
  20. Yan BX, Sun YQ. Glycine residues provide flexibility for enzyme active sites. J Biol Chem 1997; 272:3190–3194 [View Article][PubMed]
    [Google Scholar]
  21. Serrano L, Neira JL, Sancho J, Fersht AR. Effect of alanine versus glycine in alpha-helices on protein stability. Nature 1992; 356:453–455 [View Article][PubMed]
    [Google Scholar]
  22. Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL et al. The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxid Redox Signal 2017; 27:684–712 [View Article][PubMed]
    [Google Scholar]
  23. Rudnicki WR, Mroczek T, Cudek P. Amino acid properties conserved in molecular evolution. PLoS One 2014; 9:e98983 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000889
Loading
/content/journal/micro/10.1099/mic.0.000889
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error